Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Thrombocytopenia,Unspecified”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05583838
What this trial is testing

Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Who this might be right for
Previously Treated Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 157
Not applicableLooking for participantsNCT04890041
What this trial is testing

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

Who this might be right for
Primary Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006
What this trial is testing

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Thrombocytopenia, Immune
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT07700238
What this trial is testing

Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Amgen 126
Not applicableStudy completedNCT06071520
What this trial is testing

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 50
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Large-scale testing (Phase 3)Looking for participantsNCT07233213
What this trial is testing

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableUnknownNCT04949009
What this trial is testing

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Study completedNCT01667263
What this trial is testing

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Peking University People's Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT04671901
What this trial is testing

Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, ChildhoodSolid Carcinoma
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Large-scale testing (Phase 3)Active Not RecruitingNCT03165734
What this trial is testing

Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum 407
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Early research (Phase 1)Looking for participantsNCT07206758
What this trial is testing

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd 10
Large-scale testing (Phase 3)Ended earlyNCT02055781
What this trial is testing

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
CTI BioPharma 311
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Next Page